Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

ASMBASSEMBLY BIOSCIENCES, INC.

Nasdaq · CIK 0001426800
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts455

Identity from submissions API

NameASSEMBLY BIOSCIENCES, INC.
CIK0001426800
TickersASMB
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(833) 409-4583
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • VENTRUS BIOSCIENCES INC (2008-02-07T05:00:00.000Z → 2014-07-11T04:00:00.000Z)
Business address
TWO TOWER PLACE
7TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
TWO TOWER PLACE
7TH FLOOR
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

904 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000264 005-85836 261558441 34 13233
2026-11-12 10-Q 10-Q 0001193125-26-458441 001-35005 261547169 34 10050914 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-458314 001-35005 261546772 34 462068 1 1
2026-11-03 4 4 0001193125-26-445553 9491
2026-11-03 4 4 0001193125-26-445537 9497
2026-11-03 4 4 0001193125-26-445507 5185
2026-11-03 4 4 0001193125-26-445486 9485
2026-11-03 4 4 0001193125-26-445460 9490
2026-11-02 144 xsl144X01/primary_doc.xml 0001193125-26-444010 001-35005 261513920 33 4377
2026-11-02 144 xsl144X01/primary_doc.xml 0001193125-26-444003 001-35005 261513917 33 4366
2026-11-02 144 xsl144X01/primary_doc.xml 0001193125-26-444000 001-35005 261513906 33 4434
2026-08-20 S-8 S-8 0001193125-26-359252 333-298463 261300329 33 402927 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-097209 005-85836 261282246 34 12705
2026-08-14 8-K/A 8-K/A 2.02,9.01 0001193125-26-352193 001-35005 261281213 34 466854 1 1
2026-08-13 10-Q 10-Q 0001193125-26-349236 001-35005 261273624 34 9204829 1 1
2026-08-13 8-K 8-K 2.01,9.01 0001193125-26-349198 001-35005 261273453 34 460347 1 1
2026-08-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000208 005-85836 261271758 34 13543
2026-08-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000908834-26-000380 005-85836 261235641 34 46559
2026-06-18 4 4 0001193125-26-275804 5322
2026-06-05 4 4 0001193125-26-259927 5771
2026-06-05 4 4 0001193125-26-259924 5758
2026-06-05 4 4 0001193125-26-259855 5593
2026-06-05 4 4 0001193125-26-259822 5581
2026-06-05 4 4 0001193125-26-259808 5593
2026-06-05 4 4 0001193125-26-259776 5599
2026-06-05 4 4 0001193125-26-259742 5527
2026-06-05 4 4 0001193125-26-259697 5529
2026-06-05 4 4 0001193125-26-259661 5555
2026-06-05 4 4 0001193125-26-259562 5791
2026-06-05 4 4 0001193125-26-259517 5774
2026-06-05 8-K 8-K 5.02,5.07,9.01 0001193125-26-259481 001-35005 261068900 34 222523 1 1
2026-05-27 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001123292-26-000751 4970
2026-05-27 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001123292-26-000750 005-85836 261028254 34 28563
2026-05-26 8-K 8-K 1.01,8.01,9.01 0001193125-26-239277 001-35005 261019874 34 999839 1 1
2026-05-26 424B5 424B5 0001193125-26-237361 333-294459 261015538 33 647987 1 1
2026-05-22 424B5 424B5 0001193125-26-236812 333-294459 261013513 33 536983
2026-05-22 8-K 8-K 7.01,8.01,9.01 0001193125-26-235469 001-35005 261010725 34 195000 1 1
2026-05-11 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-058623 005-85836 26963036 34 16332
2026-05-07 10-Q 10-Q 0001193125-26-211987 001-35005 26953624 34 7627961 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211922 001-35005 26953397 34 387010 1 1
2026-04-22 DEFA14A DEFA14A 0001193125-26-170508 001-35005 26884104 34 2446440 1 1
2026-04-22 DEF 14A DEF 14A 0001193125-26-170417 001-35005 26883918 34 5312320 1 1
2026-04-22 ARS ARS 0001193125-26-170355 001-35005 26883712 34 13130975
2026-03-31 4 4 0001193125-26-134669 9980
2026-03-31 4 4 0001193125-26-134645 9780
2026-03-31 4 4 0001193125-26-134601 5684
2026-03-31 4 4 0001193125-26-134554 5699
2026-03-31 4 4 0001193125-26-134496 5696
2026-03-30 8-K 8-K 5.02,9.01 0001193125-26-131872 001-35005 26813375 34 290886 1 1
2026-03-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000970 333-294459 26809742 33 1875
2026-03-25 CORRESP filename1.htm 0001193125-26-124050 24857
2026-03-24 UPLOAD filename1.pdf 0000000000-26-002988 333-294459 40294
2026-03-19 S-3 S-3 0001193125-26-116161 333-294459 26775090 33 975446 1 1
2026-03-19 S-8 S-8 0001193125-26-116132 333-294449 26774961 33 186123 1 1
2026-03-19 10-K 10-K 0001193125-26-115992 001-35005 26774408 34 13412007 1 1
2026-03-19 8-K 8-K 2.02,9.01 0001193125-26-115980 001-35005 26774336 34 419267 1 1
2026-02-09 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-26-000058 005-85836 26609744 34 57810
2025-12-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-311251 001-35005 251556324 34 317546 1 1
2025-12-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001274173-25-000331 005-85836 251555150 34 9551
2025-11-21 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003347 333-290866 251509466 33 1876
2025-11-21 424B3 424B3 0001193125-25-291512 333-290866 251508674 33 169513
2025-11-19 CORRESP filename1.htm 0001193125-25-288088 63659
2025-11-10 10-Q 10-Q 0001193125-25-274277 001-35005 251466425 34 10195178 1 1
2025-11-10 8-K 8-K 2.02,9.01 0001193125-25-274235 001-35005 251466280 34 488387 1 1
2025-10-14 S-3 S-3 0001193125-25-239048 333-290866 251392009 33 406564 1 1
2025-10-03 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 0001123292-25-000510 11111
2025-08-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-022200 005-85836 251229055 34 20009
2025-08-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001339 005-85836 251228134 34 7781
2025-08-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000908834-25-000255 005-85836 251225997 34 58241
2025-08-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001831942-25-000017 005-85836 251224502 34 15967
2025-08-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001246 005-85836 251208139 34 7402
2025-08-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001123292-25-000353 005-85836 251207185 34 31043
2025-08-11 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-25-178092 001-35005 251203124 34 1205704 1 1
2025-08-11 424B5 424B5 0001193125-25-177435 333-285970 251200110 33 636593
2025-08-11 424B5 424B5 0001193125-25-177403 333-285970 251199990 33 636763
2025-08-08 8-K 8-K 7.01,8.01,9.01 0001193125-25-176138 001-35005 251196295 34 186387 1 1
2025-08-07 S-3MEF S-3MEF 0001193125-25-175697 333-289395 251196013 33 244490 1 1
2025-08-06 S-8 S-8 0000950170-25-104118 333-289300 251190014 33 393451 1 1
2025-08-06 10-Q 10-Q 0000950170-25-104060 001-35005 251189799 34 8504045 1 1
2025-08-06 8-K 8-K 2.02,8.01,9.01 0000950170-25-104020 001-35005 251189646 34 505925 1 1
2025-06-25 8-K 8-K 8.01,9.01 0000950170-25-089949 001-35005 251073673 34 195204 1 1
2025-06-17 4 4 0000950170-25-087346 7319
2025-06-09 8-K 8-K 5.02,5.07,9.01 0000950170-25-083830 001-35005 251034886 34 253359 1 1
2025-06-09 4 4 0000950170-25-083704 5404
2025-06-09 4 4 0000950170-25-083703 5331
2025-06-09 4 4 0000950170-25-083702 5338
2025-06-09 4 4 0000950170-25-083700 5402
2025-06-09 4 4 0000950170-25-083695 5232
2025-06-09 4 4 0000950170-25-083694 5377
2025-06-09 4 4 0000950170-25-083693 5384
2025-05-08 10-Q 10-Q 0000950170-25-066991 001-35005 25926321 34 7253130 1 1
2025-05-08 8-K 8-K 2.02,9.01 0000950170-25-066946 001-35005 25926131 34 412268 1 1
2025-04-23 DEFA14A DEFA14A 0000950170-25-057414 001-35005 25861746 34 346348
2025-04-23 DEF 14A DEF 14A 0000950170-25-057353 001-35005 25861541 34 7512785 1 1
2025-04-23 ARS ARS 0000950170-25-057331 001-35005 25861378 34 4347542
2025-04-15 4 4 0000950170-25-054331 5540
2025-04-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000925 333-285970 25801855 33 1875
2025-04-01 4 4 0000950170-25-048488 6519
2025-04-01 4 4 0000950170-25-048487 9786
2025-04-01 4 4 0000950170-25-048486 8320
2025-04-01 4 4 0000950170-25-048485 8098
2025-04-01 4 4 0000950170-25-048483 5606
2025-03-28 CORRESP filename1.htm 0001193125-25-067061 11096
2025-03-26 UPLOAD filename1.pdf 0000000000-25-003257 333-285970 40272
2025-03-20 S-3 S-3 0001193125-25-059320 333-285970 25757150 33 488820
2025-03-20 10-K 10-K 0000950170-25-042673 001-35005 25756625 34 13013018 1 1
2025-03-20 8-K 8-K 2.02,9.01 0000950170-25-042660 001-35005 25756523 34 389666 1 1
2025-02-20 8-K 8-K 8.01,9.01 0000950170-25-024134 001-35005 25645233 34 206920 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-001235 005-85836 25630483 34 10734
2025-01-03 8-K 8-K 1.01,2.03,9.01 0000950170-25-001141 001-35005 25505951 34 393297 1 1
2024-12-31 4 4 0000950170-24-141616 5162
2024-12-26 8-K 8-K 8.01,9.01 0000950170-24-139962 001-35005 241576444 34 200483 1 1
2024-12-23 4 xslF345X05/ownership.xml 0000904454-24-000669 5020
2024-12-23 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000904454-24-000667 005-85836 241575384 34 24070
2024-12-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-24-001755 005-85836 241575077 34 6293
2024-12-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-24-001750 005-85836 241571514 34 6173
2024-12-19 8-K 8-K 1.01,3.02,9.01 0000950170-24-138242 001-35005 241561019 34 230071 1 1
2024-12-13 8-K 8-K 5.03,9.01 0000950170-24-136183 001-35005 241548334 34 542255 1 1
2024-11-26 4 xslF345X05/ownership.xml 0001079973-24-001637 9458
2024-11-19 4 4 0000950170-24-128557 5195
2024-11-14 SC 13G armistice-asmb093024.htm 0001172661-24-005070 005-85836 241460916 34 90666
2024-11-07 8-K 8-K 1.01,9.01 0000950170-24-123466 001-35005 241436749 34 675934 1 1
2024-11-07 424B5 424B5 0001193125-24-253253 333-270760 241436640 33 394504
2024-11-07 10-Q 10-Q 0000950170-24-123402 001-35005 241436216 34 6682430 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-123355 001-35005 241435893 34 416506 1 1
2024-10-09 4 xslF345X05/ownership.xml 0001079973-24-001375 5394
2024-10-04 4 4 0000950170-24-112897 5196
2024-10-04 4 4 0000950170-24-112896 5186
2024-09-23 8-K 8-K 8.01,9.01 0000950170-24-108629 001-35005 241314663 34 209641 1 1
2024-08-08 S-8 S-8 0000950170-24-094089 333-281388 241189010 33 200417
2024-08-08 10-Q 10-Q 0000950170-24-093998 001-35005 241188556 34 6599212 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093946 001-35005 241188360 34 427538 1 1
2024-08-05 4 4 0000950170-24-090743 5681
2024-08-05 4 4 0000950170-24-090724 5671
2024-07-08 4 xslF345X05/ownership.xml 0001079973-24-001035 7450
2024-06-24 SC 13D/A SCHEDULE 13D/A 0001079973-24-000954 005-85836 241064682 34 46588
2024-06-20 SC 13D/A s13da_061724-assemblybio.htm 0000904454-24-000393 005-85836 241058166 34 59779
2024-06-20 4 xslF345X05/ownership.xml 0000904454-24-000391 8115
2024-06-18 8-K 8-K 1.01,3.02,9.01 0001193125-24-163398 001-35005 241051748 34 817829 1 1
2024-06-18 424B5 424B5 0001193125-24-163394 333-270760 241051724 33 467331
2024-06-03 8-K 8-K 5.02,5.07,9.01 0000950170-24-067951 001-35005 241013575 34 468694 1 1
2024-05-30 4 4 0000950170-24-066606 5409
2024-05-30 4 4 0000950170-24-066605 5345
2024-05-30 4 4 0000950170-24-066604 5338
2024-05-30 4 4 0000950170-24-066585 5411
2024-05-30 4 4 0000950170-24-066584 5391
2024-05-30 4 4 0000950170-24-066562 5384
2024-05-30 4 4 0000950170-24-066560 5239
2024-05-24 4 4 0000950170-24-064589 5692
2024-05-24 4 4 0000950170-24-064586 5550
2024-05-24 4 4 0000950170-24-064551 5680
2024-05-24 4 4 0000950170-24-064552 5887
2024-05-08 10-Q 10-Q 0000950170-24-055680 001-35005 24926299 34 5506192 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055650 001-35005 24926098 34 354858 1 1
2024-05-01 4 4 0000950170-24-051271 7317
2024-05-01 4 4 0000950170-24-051244 7307
2024-05-01 4 4 0000950170-24-051243 5219
2024-04-17 DEFA14A DEFA14A 0000950170-24-045122 001-35005 24851232 34 412895
2024-04-17 DEF 14A DEF 14A 0000950170-24-045105 001-35005 24851124 34 3426876 1 1
2024-04-17 ARS ARS 0000950170-24-045094 001-35005 24850987 34 4754222
2024-04-02 4 4 0000950170-24-040205 5883
2024-04-02 4 4 0000950170-24-040180 10127
2024-04-02 4 4 0000950170-24-040162 8440
2024-04-02 4 4 0000950170-24-040149 5633
2024-04-02 4 4 0000950170-24-040132 8097
2024-03-29 4 4 0000950170-24-038630 5534
2024-03-28 10-K 10-K 0000950170-24-038057 001-35005 24799149 34 11117470 1 1
2024-03-28 8-K 8-K 2.02,9.01 0000950170-24-038044 001-35005 24798980 34 342079 1 1
2024-03-15 3 3 0000950170-24-032184 12537
2024-03-15 8-K 8-K 5.02,9.01 0000950170-24-032162 001-35005 24754666 34 240977 1 1
2024-02-13 8-K 8-K 3.03,5.03,8.01,9.01 0000950170-24-014534 001-35005 24625660 34 208251 1 1
2024-02-02 8-K 8-K 5.07,8.01 0000950170-24-010475 001-35005 24591324 34 173257 1 1
2024-01-19 4 xslF345X05/ownership.xml 0001079973-24-000085 7361
2024-01-17 8-K 8-K 1.02 0000950170-24-005024 001-35005 24538434 34 185786 1 1
2023-12-21 DEFA14A DEFA14A 0001193125-23-301186 001-35005 231505361 34 144674
2023-12-21 DEF 14A DEF 14A 0001193125-23-301174 001-35005 231505259 34 691376
2023-12-11 PRE 14A PRE 14A 0001193125-23-292566 001-35005 231478235 34 691834
2023-12-11 3 FORM 3 SUBMISSION 0001209191-23-058037 7427
2023-12-07 8-K 8-K 5.02,8.01 0000950170-23-068794 001-35005 231472371 34 197074 1 1
2023-11-22 SC 13D/A SCHEDULE 13D/A 0001079973-23-001646 005-85836 231433548 34 48421
2023-11-22 4 xslF345X05/ownership.xml 0001079973-23-001645 7294
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056212 5372
2023-11-13 4 FORM 4 SUBMISSION 0001209191-23-054973 5800
2023-11-13 3 FORM 3 SUBMISSION 0001209191-23-054970 7522
2023-11-08 10-Q 10-Q 0000950170-23-061134 001-35005 231388069 34 9760016 1 1
2023-11-08 8-K 8-K 2.02,9.01 0000950170-23-061105 001-35005 231387910 34 456781 1 1
2023-11-03 SC 13D/A SCHEDULE 13D/A 0001079973-23-001529 005-85836 231376280 34 39785
2023-10-31 SC 13D FormSC13D.txt 0001999256-23-000003 005-85836 231364782 34 8074
2023-10-31 3 PRIMARY DOCUMENT 0001999256-23-000001 4255
2023-10-25 3 PRIMARY DOCUMENT 0000904454-23-000579 4016
2023-10-25 SC 13D SCHEDULE 13D 0000904454-23-000577 005-85836 231346848 34 70940
2023-10-17 8-K 8-K 1.01,3.02,9.01 0001193125-23-257271 001-35005 231328445 34 1591737 1 1
2023-10-04 4 FORM 4 SUBMISSION 0001209191-23-051934 7809
2023-10-04 4 FORM 4 SUBMISSION 0001209191-23-051910 7818
2023-10-04 4 FORM 4 SUBMISSION 0001209191-23-051888 7801
2023-10-03 144 xsl144X01/primary_doc.xml 0000950170-23-051732 001-35005 231306109 33 5112
2023-10-03 144 xsl144X01/primary_doc.xml 0000950170-23-051731 001-35005 231306102 33 5048
2023-09-29 8-K 8-K 3.01 0000950170-23-050808 001-35005 231296120 34 171293 1 1
2023-09-18 3 FORM 3 SUBMISSION 0001209191-23-049813 15988
2023-08-09 S-8 S-8 0000950170-23-040658 333-273836 231155625 33 275701
2023-08-09 10-Q 10-Q 0000950170-23-040626 001-35005 231155440 34 7383133 1 1
2023-08-09 8-K 8-K 2.02,9.01 0000950170-23-040590 001-35005 231155272 34 497038 1 1
2023-08-07 8-K 8-K 1.01,2.03 0000950170-23-039043 001-35005 231147558 34 184511 1 1
2023-08-03 4 FORM 4 SUBMISSION 0001209191-23-044405 5865
2023-08-03 4 FORM 4 SUBMISSION 0001209191-23-044397 5849
2023-08-02 144 xsl144X01/primary_doc.xml 0000950170-23-037389 001-35005 231137348 33 5145
2023-08-02 144 xsl144X01/primary_doc.xml 0000950170-23-037386 001-35005 231137331 33 5809
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043309 5867
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039532 5296
2023-06-23 4 FORM 4 SUBMISSION 0001209191-23-039531 5279
2023-05-31 4 FORM 4 SUBMISSION 0001209191-23-033100 5864
2023-05-30 144 xsl144X01/primary_doc.xml 0000950170-23-024977 001-35005 23978119 33 5804
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032904 5419
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032900 5526
2023-05-30 8-K 8-K 5.02,5.07,9.01 0000950170-23-024879 001-35005 23976939 34 244414 1 1
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032891 5518
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032884 5584
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032874 5592
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032867 5572
2023-05-30 4 FORM 4 SUBMISSION 0001209191-23-032862 5564
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031919 7675
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031918 8032
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031912 8030
2023-05-24 4 FORM 4 SUBMISSION 0001209191-23-031899 7794
2023-05-23 144 xsl144X01/primary_doc.xml 0000950170-23-023696 001-35005 23950132 33 5103
2023-05-23 144 xsl144X01/primary_doc.xml 0000950170-23-023695 001-35005 23950129 33 5832
2023-05-23 144 xsl144X01/primary_doc.xml 0000950170-23-023694 001-35005 23950122 33 4914
2023-05-04 10-Q 10-Q 0000950170-23-017931 001-35005 23889322 34 6444372 1 1
2023-05-04 8-K 8-K 2.02,9.01 0000950170-23-017924 001-35005 23889203 34 438888 1 1
2023-04-18 8-K 8-K 8.01,9.01 0000950170-23-013272 001-35005 23826878 34 230256 1 1
2023-04-14 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-04-14 16:30:00 9999999995-23-000944 333-270760 23822710 33 1853
2023-04-12 CORRESP filename1.htm 0000950170-23-012568 32411
2023-04-12 DEFA14A DEFA14A 0000950170-23-012565 001-35005 23815871 34 256280
2023-04-12 DEF 14A DEF 14A 0000950170-23-012560 001-35005 23815802 34 3895394
2023-04-12 ARS ARS 0000950170-23-012555 001-35005 23815714 34 3317710
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021886 5746
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021882 12697
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021874 8471
2023-03-31 4 FORM 4 SUBMISSION 0001209191-23-021868 8454
2023-03-31 PRE 14A PRE 14A 0000950170-23-011369 001-35005 23787563 34 3898493
2023-03-28 4 FORM 4 SUBMISSION 0001209191-23-021385 5864
2023-03-24 UPLOAD filename1.pdf 0000000000-23-002955 40402
2023-03-22 S-3 S-3 0001193125-23-076827 333-270760 23753772 33 435143
2023-03-22 10-K 10-K 0000950170-23-009184 001-35005 23753133 34 14001632 1 1
2023-03-22 8-K 8-K 2.02,8.01,9.01 0000950170-23-009175 001-35005 23753031 34 482080 1 1
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010529 5490
2023-02-17 4 FORM 4 SUBMISSION 0001209191-23-010495 5250
2023-02-15 8-K 8-K 8.01,9.01 0000950170-23-002893 001-35005 23635390 34 215035 1 1
2023-02-14 SC 13G/A deeptrack-asmb123122a2.htm 0001172661-23-000819 005-85836 23622795 34 102992
2022-12-19 8-K 8-K 8.01,9.01 0000950170-22-026736 001-35005 221471101 34 241396 1 1
2022-12-12 8-K 8-K 5.02,5.03,9.01 0000950170-22-026384 001-35005 221457182 34 606989 1 1
2022-11-08 10-Q 10-Q 0000950170-22-023233 001-35005 221369143 34 9070249 1 1
2022-11-08 8-K 8-K 2.02,9.01 0000950170-22-023218 001-35005 221369015 34 549173 1 1
2022-10-05 8-K 8-K 5.02,7.01,9.01 0000950170-22-019311 001-35005 221296032 34 223167 1 1
2022-09-13 3 FORM 3 SUBMISSION 0001209191-22-049723 15523
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045239 5494
2022-08-09 S-8 S-8 0001564590-22-028788 333-266711 221149111 33 159237
2022-08-09 10-Q 10-Q 0001564590-22-028763 001-35005 221148543 34 8205495 1 1
2022-08-09 8-K 8-K 2.02,9.01 0001564590-22-028755 001-35005 221148388 34 487825 1 1
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044274 5782
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044229 5767
2022-07-26 4 FORM 4 SUBMISSION 0001209191-22-043216 5758
2022-07-20 8-K 8-K 2.05,5.02,7.01,9.01 0001564590-22-026043 001-35005 221094352 34 211335 1 1
2022-06-02 4 FORM 4 SUBMISSION 0001209191-22-033582 5783
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032606 5485
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032572 5551
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032569 5559
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032562 5535
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032555 5539
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032544 5531
2022-05-27 4 FORM 4 SUBMISSION 0001209191-22-032539 5386
2022-05-27 8-K 8-K 5.02,5.03,5.07,9.01 0001564590-22-021631 001-35005 22977374 34 263222 1 1
2022-05-24 8-K 8-K 8.01 0001564590-22-021134 001-35005 22956672 34 161532 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019879 001-35005 22918086 34 7196612 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001564590-22-019860 001-35005 22917919 34 444480 1 1
2022-04-12 DEFA14A DEFA14A 0001564590-22-014236 001-35005 22822384 34 1986159
2022-04-12 DEF 14A DEF 14A 0001564590-22-014232 001-35005 22822323 34 3530722
2022-04-01 PRE 14A PRE 14A 0001564590-22-013228 001-35005 22798212 34 3528684
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021781 13333
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021777 13120
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021774 13359
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021772 13159
2022-03-31 4 FORM 4 SUBMISSION 0001209191-22-021770 13093
2022-03-29 4 FORM 4 SUBMISSION 0001209191-22-021535 5844
2022-03-11 10-K 10-K 0001564590-22-009855 001-35005 22733174 34 12986617 1 1
2022-03-10 8-K 8-K 2.02,9.01 0001564590-22-009647 001-35005 22729227 34 430298 1 1
2022-02-15 SC 13G/A SC 13G/A 0001193125-22-042410 005-85836 22635944 34 68839
2022-02-14 SC 13G/A CONSONANCE CAPITAL MANAGEMENT LP 0001085146-22-001033 005-85836 22629812 34 46669
2022-02-14 SC 13G/A deeptrack-asmb123121a1.htm 0001172661-22-000417 005-85836 22625812 34 102983
2022-02-10 SC 13G/A SC 13G/A 0001193125-22-034427 005-85836 22613939 34 43851
2022-02-09 SC 13G/A SCHEDULE 13G/A 0001104659-22-016543 005-85836 22606462 34 13134
2022-02-04 8-K 8-K 5.02,9.01 0001564590-22-003953 001-35005 22593989 34 265385 1 1
2022-01-04 8-K 8-K 8.01,9.01 0001564590-22-000274 001-35005 22505692 34 192560 1 1
2021-11-04 10-Q 10-Q 0001564590-21-054499 001-35005 211380230 34 10030178 1 1
2021-11-04 8-K 8-K 2.02,9.01 0001564590-21-054487 001-35005 211380091 34 521637 1 1
2021-10-12 SC 13G deeptrack-asmb100821.htm 0001172661-21-002028 005-85836 211319166 34 102960
2021-09-01 8-K 8-K 8.01,9.01 0001564590-21-046744 001-35005 211230115 34 194672 1 1
2021-08-10 4 FORM 4 SUBMISSION 0001209191-21-050645 5488
2021-08-05 S-8 S-8 0001564590-21-041724 333-258516 211149491 33 162908
2021-08-05 10-Q 10-Q 0001564590-21-041680 001-35005 211149135 34 9900224 1 1
2021-08-05 8-K 8-K 2.02,9.01 0001564590-21-041579 001-35005 211148180 34 523212 1 1
2021-08-03 8-K 8-K 5.02 0001564590-21-040208 001-35005 211139618 34 175108 1 1
2021-07-22 4 FORM 4 SUBMISSION 0001209191-21-047818 5020
2021-07-20 4 FORM 4 SUBMISSION 0001209191-21-047430 5563
2021-07-20 3 FORM 3 SUBMISSION 0001209191-21-047414 7501
2021-07-20 8-K 8-K 5.02,9.01 0001564590-21-037262 001-35005 211101821 34 209903 1 1
2021-07-12 SC 13G/A us0453961080_071021.txt 0000834237-21-008784 005-85836 211084446 34 12474
2021-06-04 3 FORM 3 SUBMISSION 0001209191-21-038298 18121
2021-06-01 4 FORM 4 SUBMISSION 0001209191-21-036880 5762
2021-06-01 8-K 8-K 5.02 0001564590-21-031170 001-35005 21985573 34 165212 1 1
2021-05-25 8-K 8-K 5.02,5.07,9.01 0001564590-21-029780 001-35005 21960788 34 270606 1 1
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035412 5386
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035404 5485
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035400 5551
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035388 5525
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035379 5535
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035371 5539
2021-05-24 4 FORM 4 SUBMISSION 0001209191-21-035366 5531
2021-05-24 3 FORM 3 SUBMISSION 0001209191-21-035359 7526
2021-05-06 10-Q 10-Q 0001564590-21-025060 001-35005 21898489 34 8373956 1 1
2021-05-06 8-K Q1 EARNINGS RELEASE 8-K 2.02,9.01 0001564590-21-025022 001-35005 21898212 34 443974 1 1
2021-04-07 DEFA14A DEFA14A 0001564590-21-018015 001-35005 21812274 34 146718
2021-04-07 DEF 14A DEF 14A 0001564590-21-018007 001-35005 21812193 34 2861962
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024643 7670
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024640 7637
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024636 7630
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024631 7873
2021-04-02 4 FORM 4 SUBMISSION 0001209191-21-024621 5702
2021-02-26 8-K 8-K 8.01,9.01 0001564590-21-009406 001-35005 21688527 34 240020 1 1
2021-02-25 10-K 10-K 0001564590-21-008878 001-35005 21680789 34 14005189 1 1
2021-02-25 8-K 8-K 2.02,8.01,9.01 0001564590-21-008834 001-35005 21680458 34 560584 1 1
2021-02-17 8-K 8-K 5.02,9.01 0001564590-21-006414 001-35005 21645709 34 275991 1 1
2021-02-17 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-001029 005-85836 21644210 34 58378
2021-02-16 SC 13G d8805009.htm 0000919574-21-001703 005-85836 21640755 34 97890
2021-02-16 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000914 005-85836 21638762 34 57915
2021-02-16 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-21-000936 005-85836 21636441 34 58378
2021-02-12 SC 13G/A SC 13G/A 0001193125-21-039839 005-85836 21622659 34 45151
2021-02-11 UPLOAD filename1.pdf 0000000000-21-001755 39793
2021-02-10 SC 13G/A 13G AMENDED ANNUAL FILING (ASMB) 0000053417-21-000007 005-85836 21611814 34 8936
2021-02-10 SC 13G SCHEDULE 13G 0001104659-21-017496 005-85836 21610096 34 13968
2021-02-09 SC 13G/A asse.htm 0001137774-21-000019 005-85836 21605128 34 9852
2021-01-29 SC 13G/A us0453961080_012821.txt 0000834237-21-002858 005-85836 21566832 34 13480
2021-01-27 8-K 8-K 5.03,8.01,9.01 0001564590-21-002592 001-35005 21559679 34 473458 1 1
2021-01-12 CORRESP filename1.htm 0001564590-21-000997 40511
2021-01-04 SC 13G SC 13G 0001193125-21-000943 005-85836 21501765 34 45151
2020-12-29 UPLOAD filename1.pdf 0000000000-20-012508 45294
2020-12-15 4 FORM 4 SUBMISSION 0001209191-20-063666 5555
2020-12-08 8-K 8-K-12082020 2.05,5.02,9.01 0001564590-20-056460 001-35005 201375394 34 191990 1 1
2020-11-17 8-K 8-K 8.01,9.01 0001564590-20-054361 001-35005 201321233 34 193588 1 1
2020-11-10 4 FORM 4 SUBMISSION 0001209191-20-057783 5531
2020-11-05 10-Q 10-Q 0001564590-20-051470 001-35005 201291566 34 11038634 1 1
2020-11-05 8-K 8-K 2.02,8.01,9.01 0001564590-20-051400 001-35005 201291149 34 603598 1 1
2020-10-21 4 FORM 4 SUBMISSION 0001209191-20-055491 5567
2020-10-21 3 FORM 3 SUBMISSION 0001209191-20-055488 7479
2020-10-21 8-K 8-K 5.02,9.01 0001564590-20-047123 001-35005 201251086 34 182305 1 1
2020-09-04 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-09-04 16:00:00 9999999995-20-002378 333-248469 201162857 33 1854
2020-09-03 CORRESP filename1.htm 0001193125-20-238947 15602
2020-09-02 UPLOAD filename1.pdf 0000000000-20-008294 40478
2020-08-28 S-8 S-8 0001564590-20-041777 333-248476 201148129 33 179205
2020-08-28 S-3 S-3 0001193125-20-234664 333-248469 201147920 33 777115
2020-08-27 8-K 8-K082020 8.01,9.01 0001564590-20-041552 001-35005 201143298 34 208246 1 1
2020-08-10 4 FORM 4 SUBMISSION 0001209191-20-045952 7540
2020-08-05 10-Q 10-Q 0001564590-20-036859 001-35005 201078066 34 10355136 1 1
2020-08-05 8-K Q2 EARNINGS 2.02,9.01 0001564590-20-036846 001-35005 201077659 34 532686 1 1
2020-07-20 8-K 8-K (BD) 1.01,8.01,9.01 0001564590-20-032666 001-35005 201034979 34 228759 1 1
2020-06-18 8-K 8-K 1.02,9.01 0001564590-20-029795 001-35005 20972676 34 191695 1 1
2020-06-16 8-K 8-K 5.02,5.03,5.07,9.01 0001564590-20-029542 001-35005 20966856 34 580429 1 1
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036642 6964
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036640 5487
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036637 5481
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036636 5487
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036632 5527
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036630 5537
2020-06-15 4 FORM 4 SUBMISSION 0001209191-20-036627 5533
2020-05-29 4 FORM 4 SUBMISSION 0001209191-20-032903 7631
2020-05-29 3 FORM 3 SUBMISSION 0001209191-20-032892 7582
2020-05-19 DEFA14A DEFA14A 0001564590-20-026175 001-35005 20894025 34 64330
2020-05-08 10-Q 10-Q 0001564590-20-023566 001-35005 20860693 34 9026425 1 1
2020-05-07 8-K 8-K 2.02,9.01 0001564590-20-022900 001-35005 20856847 34 470933 1 1
2020-04-27 DEFA14A DEFA14A 0001564590-20-018827 001-35005 20820193 34 240184
2020-04-27 DEF 14A DEF 14A 0001564590-20-018818 001-35005 20820055 34 2307359
2020-04-16 PRE 14A PRE 14A 0001564590-20-017065 001-35005 20796590 34 2336091
2020-03-31 4 FORM 4 SUBMISSION 0001209191-20-021800 9926
2020-03-31 4 FORM 4 SUBMISSION 0001209191-20-021798 9796
2020-03-31 4 FORM 4 SUBMISSION 0001209191-20-021797 5044
2020-03-31 4 FORM 4 SUBMISSION 0001209191-20-021796 7538
2020-03-30 4 FORM 4 SUBMISSION 0001209191-20-021709 7659
2020-03-30 3 FORM 3 SUBMISSION 0001209191-20-021707 8192
2020-03-04 10-K 10-K 0001564590-20-008696 001-35005 20687659 34 12566009 1 1
2020-03-04 8-K EARNINGS RELEASE - Q4/FY 2019 2.02,9.01 0001564590-20-008685 001-35005 20687268 34 494285 1 1
2020-02-26 SEC STAFF LETTER filename1.pdf 9999999997-20-001013 227284
2020-02-14 SC 13G/A rocksprings-asmb133119a1.htm 0001172661-20-000736 005-85836 20617652 34 109866
2020-02-14 SC 13G CONSONANCE CAPITAL MANAGEMENT LP 0001085146-20-000756 005-85836 20616907 34 58412
2020-02-14 SC 13G/A d8477783_13g-a.htm 0000919574-20-001436 005-85836 20615835 34 119491
2020-02-11 8-K 2020 BONUS PLAN 5.02,9.01 0001564590-20-004234 001-35005 20597397 34 247522 1 1
2020-02-11 SEC STAFF LETTER filename1.pdf 9999999997-20-000630 154021
2020-02-05 SC 13G/A us0453961080_020420.txt 0000834237-20-004662 005-85836 20576941 34 13438
2020-02-04 SC 13G/A 13G AMENDED ANNUAL FILING (ASMB) 0000053417-20-000029 005-85836 20573302 34 9980
2020-02-03 SC 13G/A asse.htm 0001137774-20-000021 005-85836 20567168 34 9199
2020-01-08 SC 13G/A SEC SCHEDULE 13G 0000902219-20-000041 005-85836 20515545 34 33589

Latest XBRL company facts

One latest value per concept from companyfacts (455 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 20.48M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
dei EntityPublicFloat Entity Public Float USD 97.80M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115992
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 2.35M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-170417
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.26M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-170417
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 5.51M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-170417
ecd PeoTotalCompAmt PeoTotalCompAmt USD 2.48M 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-170417
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 218.01 2025-01-01 2025-12-31 DEF 14A 2026-04-22 0001193125-26-170417
ffd NetFeeAmt NetFeeAmt USD 6,492.02 2026-08-20 S-8 2026-08-20 0001193125-26-359252
ffd NrrtvMaxAggtOfferingPric NrrtvMaxAggtOfferingPric USD 400.00M 2026-05-22 424B5 2026-05-26 0001193125-26-237361
ffd TtlFeeAmt TtlFeeAmt USD 6,492.02 2026-08-20 S-8 2026-08-20 0001193125-26-359252
ffd TtlOfferingAmt TtlOfferingAmt USD 47.01M 2026-08-20 S-8 2026-08-20 0001193125-26-359252
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-20 S-8 2026-08-20 0001193125-26-359252
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-22 424B5 2026-05-26 0001193125-26-237361
invest InvestmentOptionsExercisePrice Investment Options, Exercise Price USD 6 2010-12-01 2010-12-22 2013 FY 10-K 2014-03-31 0001144204-14-019383
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 5.77 2011-01-01 2011-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 1.05M 2014-09-30 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 3.18M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 3.41M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 582,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 5.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 428,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AccruedVacationCurrent Accrued Vacation, Current USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 210,000 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -989,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 562.21M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.17B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 6.00M 2010-01-01 2010-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 758,948 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 904 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD -4,000 2019-01-01 2019-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 60,000 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028776
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 679,447 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 2.87M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 3.47M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AreaOfLand Area of Land acre 6,286 2015-09-30 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap Assets Assets USD 325.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AssetsCurrent Assets, Current USD 321.16M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AssetsNoncurrent Assets, Noncurrent USD 45.54M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 76,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 6,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 132.00M 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 139.55M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 97,000 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain (Loss), before Tax USD 749,495 2016-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100132
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 0 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 139.46M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss), Net of Tax (Deprecated 2018-01-31) USD -66,959 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001144204-18-025756
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 6,720 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss USD 192,407 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 51.18M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 185,687 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 50.18M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value USD 999,390 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 285.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap AvailableForSaleSecuritiesDebtSecuritiesNoncurrent Debt Securities, Available-for-sale, Noncurrent USD 0 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount Business Acquisition, Goodwill, Expected Tax Deductible Amount USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -4.50M 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028776
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 0 2014-01-01 2014-03-31 2015 Q1 10-Q 2015-05-08 0001144204-15-028776
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 29.82M 2014-06-11 2014-07-11 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets USD 42.20M 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 509,363 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other USD 23,540 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent USD 11.60M 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill USD 29.00M 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities USD 12.37M 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment USD 10,350 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 29.82M 2014-07-11 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 121,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001193125-26-349236
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 29.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 27.84M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123402
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -12.36M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 314.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 34.26M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 29.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -7.21M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -29.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 27.84M 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123402
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.001 2026-05-26 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 15,296 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 415,000 2026-05-26 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 10.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 1.90M 2018-05-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 20.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 20.37M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap CommonStocksIncludingAdditionalPaidInCapital Common Stocks, Including Additional Paid in Capital USD 75.00M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap CommonStockValue Common Stock, Value, Issued USD 20,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -34.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 29.08M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211987
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 13.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 8.21M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001193125-26-211987
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 0 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123402
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 0 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap CostOfReimbursableExpense Cost of Reimbursable Expense (Deprecated 2018-01-31) USD 200,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001144204-18-025756
us-gaap CostsAndExpenses Costs and Expenses USD 77.48M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 330,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 14.00M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.7 2007-01-01 2007-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent Debt Instrument, Convertible, Carrying Amount of Equity Component USD 1.43M 2010-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 4.2 2009-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DebtInstrumentConvertibleEffectiveInterestRate Debt Instrument, Convertible, Effective Interest Rate (Deprecated 2013-01-31) pure 0.1 2007-01-01 2007-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015576
us-gaap DebtInstrumentConvertibleInterestExpense Debt Instrument, Convertible, Interest Expense (Deprecated 2013-01-31) USD 3.78M 2010-05-07 2010-05-31 2012 FY 10-K 2013-03-18 0001144204-13-015576
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 5.62M 2010-02-26 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.1 2007-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.1 2009-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015576
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2011-12-31 2011 FY 10-K 2012-03-14 0001144204-12-014863
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostCurrent Debt Securities, Available-for-sale, Amortized Cost, Current USD 285.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostNoncurrent Debt Securities, Available-for-sale, Amortized Cost, Noncurrent USD 28.08M 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 0 2025-12-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap DebtSecuritiesRealizedGainLoss Debt Securities, Realized Gain (Loss) USD 3,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 300,000 2011-08-02 2011-08-24 2013 Q3 10-Q 2013-11-12 0001144204-13-060199
us-gaap DeferredCompensationArrangementWithIndividualDistributionsPaid Deferred Compensation Arrangement with Individual, Distributions Paid (Deprecated 2017-01-31) USD 200,000 2011-08-24 2013 Q3 10-Q 2013-11-12 0001144204-13-060199
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 26,631 2010-12-31 2011 FY 10-K 2012-03-14 0001144204-12-014863
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 697,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 2.53M 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap DeferredRentCredit Deferred Rent Credit USD 100,000 2019-01-01 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 0 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap DeferredRevenueAdditions Deferred Revenue, Additions USD 996,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 6.08M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 33.58M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 29.38M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 1.46M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 175.81M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 2.26M 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 697,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 4.90M 2017-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 123.61M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 378.80M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 446.80M 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 32,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 5.38M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 7.36M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxAssetsUnrealizedLossesOnTradingSecurities Deferred Tax Assets, Unrealized Losses on Trading Securities USD 46,000 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 175.11M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DeferredTaxLiabilitiesCurrent Deferred Tax Liabilities, Net, Current USD 3.25M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 7.44M 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs USD 341,000 2009-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 59,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap Depreciation Depreciation USD 500,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 118.26M 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 259,921 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.48 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019879
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.73 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 2.121 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.1 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.555 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.084 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 2.781 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal Effective Income Tax Rate Reconciliation, Tax Settlement, State and Local, Percent pure 0.11 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 0 2014-07-01 2014-07-31 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 0 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 15.10M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.023 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap FairValueAssumptionsWeightedAverageVolatilityRate Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) pure 1.282 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 29.00M 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD -1.63M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054499
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 15.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap Goodwill Goodwill USD 12.64M 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap GoodwillAcquiredDuringPeriod Goodwill, Acquired During Period USD 12.64M 2014-06-11 2014-07-11 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 12.60M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 99,214 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) USD 29.00M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -6.12M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 400,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxExaminationPenaltiesAccrued Income Tax Examination, Penalties Accrued USD 0 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -12.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 8.60M 2017-01-01 2017-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 615,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -118,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -3.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD -17.03M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -2.46M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -392,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -330,000 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -23.16M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 24.70M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -996,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 3.70M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD -2.56M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -94,936 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132547
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 7,121 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100132
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -2.10M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 847,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 0 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -610,957 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap IndefinitelivedIntangibleAssetsAcquired Indefinite-lived Intangible Assets Acquired USD 29.00M 2014-06-11 2014-07-11 2015 FY 10-K 2016-03-11 0001144204-16-087539
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 29.00M 2020-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap IndefiniteLivedIntangibleAssetsPeriodIncreaseDecrease Indefinite-lived Intangible Assets, Period Increase (Decrease) USD 0 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087539
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD 6.00M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 29.00M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap InterestExpense Interest Expense USD 13.85M 2005-10-07 2012-09-30 2012 Q3 10-Q 2012-11-13 0001144204-12-061299
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3.78M 2010-01-01 2010-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap InterestExpenseOther Interest Expense, Other USD 4.98M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap InterestIncomeOther Interest Income, Other USD 7.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 685,397 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 77,105 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 229,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 0 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 4.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap LeaseCost Lease, Cost USD 1.67M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 3.17M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 268,652.16 2018-06-30 2018 Q2 10-Q 2018-08-08 0001144204-18-042893
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 806,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 671,000 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 671,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 863,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 834,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 927,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054499
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 546,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap Liabilities Liabilities USD 26.49M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 325.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap LiabilitiesCurrent Liabilities, Current USD 24.92M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 38.92M 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 3.57M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001144204-18-025756
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 50.00M 2017-02-01 2017-02-10 2018 Q1 10-Q 2018-05-07 0001144204-18-025756
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 419,380 2010-12-31 2011 Q3 10-Q/A 2011-11-18 0001144204-11-065864
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 419,380 2010-12-31 2011 FY 10-K 2012-03-14 0001144204-12-014863
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 139.55M 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap MarketableSecuritiesGainLoss Marketable Securities, Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 0 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -112,000 2020-10-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 25.43M 2019-03-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 119.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 748,058 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041660
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -93.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -12.46M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041660
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -54.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD 22.59M 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041660
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -33.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD -99,214 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-11 0001144204-16-087539
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 7.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 1.27M 2010-12-31 2011 FY 10-K 2012-03-14 0001144204-12-014863
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold USD 420,000 2015-02-01 2015-02-28 2015 FY 10-K 2016-03-11 0001144204-16-087539
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 85.23M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap OperatingExpenses Operating Expenses USD 65.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -41.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OperatingLeaseCost Operating Lease, Cost USD 851,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 700,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.63M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 635,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.57M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.67M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 2.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.90M 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 21,794 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 5,032 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 4,095 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 4,075 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 4,055 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 4,537 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 106,312 2017-12-31 2017 FY 10-K 2018-03-08 0001144204-18-013474
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 10,130 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 5,958 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132547
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 122,017 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 39.10M 2016-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 5.19M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OtherAssetsCurrent Other Assets, Current USD 609,351 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132547
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 1.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, after Tax USD -138,686 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax USD 176,181 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), before Adjustment, Tax USD 44,192 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, Tax USD 56,139 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax USD 618,075 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001144204-16-132547
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -948,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 11,947 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap OtherNoncashExpense Other Noncash Expense USD 227,910 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD 5,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap PaymentsForRestructuring Payments for Restructuring USD 599,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 57,889 2005-10-07 2012-03-31 2012 Q1 10-Q 2012-05-09 0001144204-12-027148
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 1.43M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 284.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 1.09M 2007-08-10 2007-08-31 2012 FY 10-K 2013-03-18 0001144204-13-015576
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 93.67M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 140,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2019-03-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.32M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ProceedsFromBankDebt Proceeds from Bank Debt USD 800,000 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 2.23M 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 5.20M 2013-02-01 2013-02-28 2013 Q1 10-Q 2013-05-10 0001144204-13-027924
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 5.17M 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 1.15M 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 929,457 2008-06-01 2008-09-30 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 155.43M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 419,380 2005-10-07 2012-03-31 2012 Q1 10-Q 2012-05-09 0001144204-12-027148
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 190.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 11.52M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 4,684 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 5.04M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 131.59M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 48.90M 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap ProceedsFromSaleOfAvailableForSaleSecuritiesDebt Proceeds from Sale of Debt Securities, Available-for-sale USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap ProceedsFromSaleOfHeldToMaturitySecurities Proceeds from Sale of Held-to-maturity Securities USD 500,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 419,380 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 521,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 10.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -33.19M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 595,000 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 291,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 800,000 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ReimbursementRevenue Reimbursement Revenue (Deprecated 2018-01-31) USD 1.10M 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-09 0001144204-17-041660
us-gaap RepaymentsOfBankDebt Repayments of Bank Debt USD 800,000 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 419,380 2005-10-08 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 2.72M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 1.57M 2005-10-07 2014-03-31 2014 Q1 10-Q 2014-05-14 0001144204-14-030423
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 50.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ResearchAndDevelopmentInProcess Research and Development in Process USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap RestructuringAndRelatedCostCostIncurredToDate1 Restructuring and Related Cost, Cost Incurred to Date USD 6.43M 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap RestructuringAndRelatedCostExpectedCost1 Restructuring and Related Cost, Expected Cost USD 6.99M 2021-03-31 2021 Q1 10-Q 2021-05-06 0001564590-21-025060
us-gaap RestructuringAndRelatedCostIncurredCost Restructuring and Related Cost, Incurred Cost USD 5.68M 2020-01-01 2020-12-31 2020 FY 10-K 2021-02-25 0001564590-21-008878
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.3 2022-07-01 2022-07-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap RestructuringCharges Restructuring Charges USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap RestructuringCosts Restructuring Costs USD 4.30M 2020-12-01 2021-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -865.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 72.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 24.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap Revenues Revenues USD 3.88M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 8.04 2014-10-06 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap SecurityDeposit Security Deposit USD 950,515 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD -5.24M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap SeveranceCosts1 Severance Costs USD 1.00M 2022-07-01 2022-07-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 6.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 7,156 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 49.14 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 231,559 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 46.56 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 343,465 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 45.7 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 938 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 49.14 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 9.42 2015-03-31 2016 Q1 10-Q 2016-05-10 0001144204-16-100132
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Payments USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.776 2023-04-01 2023-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093998
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066991
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.023 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.012 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee shares 400,000 2018-05-01 2018-05-31 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Expirations shares 20,973 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Forfeitures shares 75,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number shares 0 2014-12-31 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 1.70M 2025-06-30 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 31.39M 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.10M 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 13.37 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-11 0001564590-22-009855
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 2,500 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 384,700 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 966,680 2012-01-01 2012-12-31 2012 FY 10-K 2013-03-18 0001144204-13-015576
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Intrinsic Value USD/shares 0 2014-01-01 2014-06-30 2014 Q2 10-Q 2014-08-14 0001144204-14-050130
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.95M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 10.04 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 57,953 2014-07-01 2014-07-10 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 43.02M 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 5.61M 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 15.9 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 6.31 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 30,000 2013-09-30 2013 Q3 10-Q 2013-11-12 0001144204-13-060199
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 11,800 2014-07-01 2014-07-10 2014 FY 10-K 2015-03-16 0001144204-15-016102
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.85 2018-05-01 2018-05-31 2019 Q3 10-Q 2019-11-07 0000950123-19-010301
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 7.24 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 49.14 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 42.92 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.54 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 8.04 2014-10-06 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap ShortTermBankLoansAndNotesPayable Short-term Bank Loans and Notes Payable USD 800,000 2010-12-31 2011 FY 10-K 2012-03-14 0001144204-12-014863
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 298.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.083 2024-02-08 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap StockIssued1 Stock Issued USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001144204-18-058118
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 4.01M 2014-06-11 2014-07-11 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 400,000 2018-05-31 2019 Q1 10-Q 2019-05-09 0001144204-19-024904
us-gaap StockIssuedDuringPeriodSharesReverseStockSplits Stock Issued During Period, Shares, Reverse Stock Splits shares 0 2024-02-09 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 293,945 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-09 0001144204-15-063729
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 29.06M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-02 0001144204-17-012234
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 14.00M 2010-01-01 2010-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019383
us-gaap StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan Stock Issued During Period, Value, Employee Stock Ownership Plan USD 289,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-22 0000950170-23-009184
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 425,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 1.76M 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 1.92M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 521,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 6.75M 2014-06-11 2014-07-11 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 0 2016-01-01 2016-12-31 2018 FY 10-K 2019-02-28 0001144204-19-011361
us-gaap SubleaseIncome Sublease Income USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap SupplementalUnemploymentBenefitsSeveranceBenefits Supplemental Unemployment Benefits, Severance Benefits USD 700,000 2022-06-30 2022 Q2 10-Q 2022-08-09 0001564590-22-028763
us-gaap TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Income Tax Expense (Benefit) USD -8.60M 2017-01-01 2017-12-31 2019 FY 10-K 2020-03-04 0001564590-20-008696
us-gaap TradingSecuritiesUnrealizedHoldingGainLoss Trading Securities, Change in Unrealized Holding Gain (Loss) USD 160,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001144204-19-037687
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 1.80M 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 3.69M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-28 0000950170-24-038057
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 317,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-20 0000950170-25-042673
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD -36.50M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap VariableLeaseCost Variable Lease, Cost USD 817,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-19 0001193125-26-115992
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 0 2014-09-30 2014 Q3 10-Q 2014-11-17 0001144204-14-069040
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 1.98M 2020-04-01 2020-06-30 2021 Q2 10-Q 2021-08-05 0001564590-21-041680
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 19.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 48.12M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019879
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 19.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458441

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →